Canada markets closed

Catalyst Pharmaceuticals, Inc. (CPRX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
14.72-0.30 (-2.00%)
At close: 04:00PM EDT
14.93 +0.21 (+1.43%)
After hours: 07:39PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 1.74B
Enterprise Value 1.60B
Trailing P/E 23.37
Forward P/E 10.01
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)4.20
Price/Book (mrq)4.48
Enterprise Value/Revenue 4.03
Enterprise Value/EBITDA 13.39

Trading Information

Stock Price History

Beta (5Y Monthly) 0.88
52-Week Change 3-13.53%
S&P500 52-Week Change 322.38%
52 Week High 317.77
52 Week Low 311.09
50-Day Moving Average 315.60
200-Day Moving Average 314.25

Share Statistics

Avg Vol (3 month) 31.33M
Avg Vol (10 day) 31.62M
Shares Outstanding 5118.01M
Implied Shares Outstanding 6120.42M
Float 8101.66M
% Held by Insiders 16.21%
% Held by Institutions 173.38%
Shares Short (Apr 15, 2024) 46.27M
Short Ratio (Apr 15, 2024) 45.42
Short % of Float (Apr 15, 2024) 46.61%
Short % of Shares Outstanding (Apr 15, 2024) 45.32%
Shares Short (prior month Mar 15, 2024) 45.83M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 17.93%
Operating Margin (ttm)37.71%

Management Effectiveness

Return on Assets (ttm)12.83%
Return on Equity (ttm)20.75%

Income Statement

Revenue (ttm)398.2M
Revenue Per Share (ttm)3.75
Quarterly Revenue Growth (yoy)82.00%
Gross Profit (ttm)N/A
EBITDA 119.69M
Net Income Avi to Common (ttm)71.41M
Diluted EPS (ttm)0.63
Quarterly Earnings Growth (yoy)36.80%

Balance Sheet

Total Cash (mrq)137.64M
Total Cash Per Share (mrq)1.17
Total Debt (mrq)3.56M
Total Debt/Equity (mrq)0.92%
Current Ratio (mrq)2.88
Book Value Per Share (mrq)3.62

Cash Flow Statement

Operating Cash Flow (ttm)143.6M
Levered Free Cash Flow (ttm)-219.49M